Bone Marrow-Derived Mesenchymal Stem Cells Mitigate Chronic Colitis and Enteric Neuropathy via Anti-Inflammatory and Anti-Oxidative Mechanisms

Scientists investigated the therapeutic potential of bone marrow-derived MSCs treatments in spontaneous chronic colitis using the Winnie mouse model which closely replicated the presentation and inflammatory profile of ulcerative colitis.